Additional file 1: of Case report: reinitiating pembrolizumab treatment after small bowel perforation
收藏数据链接：
官方服务：
资源简介：
Supplemental Materials. Table S1 Consideration of PD-L1 and/or tumor-mutation burden in clinical trials of immune checkpoint inhibitors in non-small cell lung cancer. Figure S1. Case timeline. (ZIP 74 kb)
创建时间：
2019-04-24
